
Synthbiome Inc.
UnclaimedIn-Vitro Diagnostic Substance ManufacturingAtlanta, GA
Founded
2021
Primary NAICS
325413
CAGE code
9H3V8
Federal awards
—
Overview
SynthBiome replicating the dynamic nature of human physiology in test tubes for better drug development and treatment selection.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)